# Wire Instrumentation Using Radiofrequency Energy to Impact Transseptal Efficiency

> **NCT04645342** · NA · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 75 (actual)

## Conditions studied

- Atrial Fibrillation
- Atrial Flutter

## Interventions

- **DEVICE:** Baylis Versacross RF wire
- **DEVICE:** Baylis RF needle

## Key facts

- **NCT ID:** NCT04645342
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-30
- **Primary completion:** 2022-02-02
- **Final completion:** 2022-02-02
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2023-03-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04645342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04645342, "Wire Instrumentation Using Radiofrequency Energy to Impact Transseptal Efficiency". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT04645342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*